These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4831715)

  • 61. Detection of contact hypersensitivity to corticosteroids in allergic contact dermatitis patients who do not respond to topical corticosteroids.
    Gönül M; Gül U
    Contact Dermatitis; 2005 Aug; 53(2):67-70. PubMed ID: 16033397
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Comparative clinical trial of a new trihalogenated dermatocorticoid (halometasone) versus betamethasone dipropionate].
    Schuppli R; Dressler H; Yawalkar SJ; Weirich EG
    Z Hautkr; 1983 Feb; 58(4):230-7. PubMed ID: 6342285
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo.
    Sanclemente G; Garcia JJ; Zuleta JJ; Diehl C; Correa C; Falabella R
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1359-64. PubMed ID: 18624857
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Topical steroids and UV radiation in psoriasis.
    Petrozzi JW
    Arch Dermatol; 1983 Mar; 119(3):207-10. PubMed ID: 6824358
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fluocinonide--a new topical corticosteroid. Clinical evaluation.
    Mendelson CG
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):63-5. PubMed ID: 5291635
    [No Abstract]   [Full Text] [Related]  

  • 66. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.
    DeCastro M; El-Khoury N; Parton L; Ballabh P; LaGamma EF
    J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Levels of cyclic-AMP, cyclic-GMP and betamethasone in the aqueous humor following topical administration of betamethasone in rabbit eyes.
    Baba S; Mishima H; Miyachi Y
    Hiroshima J Med Sci; 1983 Sep; 32(3):301-4. PubMed ID: 6315641
    [No Abstract]   [Full Text] [Related]  

  • 68. Topical fusidic acid/betamethasone-containing gel compared to systemic therapy in the treatment of canine acute moist dermatitis.
    Cobb MA; Edwards HJ; Jagger TD; Marshall J; Bowker KE
    Vet J; 2005 Mar; 169(2):276-80. PubMed ID: 15727921
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomized trial.
    Rotmensch S; Liberati M; Vishne TH; Celentano C; Ben-Rafael Z; Bellati U
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):493-500. PubMed ID: 10376858
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Proceedings: Pharmacokinetic/pharmacodynamic relationships for topical steroids in the vasoconstrictor test.
    Barry BW; Brace AR; Norris AC; Woodford R
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():75P. PubMed ID: 2752
    [No Abstract]   [Full Text] [Related]  

  • 71. Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup: a prospective, randomized trial.
    Amir L; Hubermann H; Halevi A; Mor M; Mimouni M; Waisman Y
    Pediatr Emerg Care; 2006 Aug; 22(8):541-4. PubMed ID: 16912619
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein.
    Huang ZR; Hung CF; Lin YK; Fang JY
    Int J Pharm; 2008 Nov; 364(1):36-44. PubMed ID: 18761396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The pharmacokinetics of external skin preparations].
    Wohlrab W; Wozniak KD; Taube KM
    Pharmazie; 1984 Sep; 39(9):614-5. PubMed ID: 6504996
    [No Abstract]   [Full Text] [Related]  

  • 74. [Testing of Ultralan-crystal-suspension in orthopedic practice].
    Konopka H
    Z Allgemeinmed; 1973 Jul; 49(21):1008-10. PubMed ID: 4585582
    [No Abstract]   [Full Text] [Related]  

  • 75. [Drug kinetics of ear-drop steroid].
    Meshitsuka K; Masuda S; Nomura Y
    Nihon Jibiinkoka Gakkai Kaiho; 1982 Dec; 85(12):1573-7. PubMed ID: 7166715
    [No Abstract]   [Full Text] [Related]  

  • 76. Influence of vehicles on the topical activity of fluorometholone.
    Tissot J; Osmundsen PE
    Acta Derm Venereol; 1966; 46(5):447-52. PubMed ID: 4162947
    [No Abstract]   [Full Text] [Related]  

  • 77. MUTUAL INDEPENDENCE OF RELEASE RATES OF STEROIDS FROM A TOPICAL VEHICLE. IMPLICATIONS FOR POTENTIALLY OPTIMAL FORMULATIONS.
    MARCUS AD; DEMPSKI RE; HIGUCHI T; DEMARCO JD
    J Pharm Sci; 1965 Mar; 54():495-6. PubMed ID: 14301603
    [No Abstract]   [Full Text] [Related]  

  • 78. [Adrenal function in topic corticotherapy].
    Alcalá-Carenzo A; Pososqa-Martinez G; Velázquez E; Barron C; Junco E; Urquieta B; Mondragón L
    Arch Invest Med (Mex); 1978; 9(2):459-68. PubMed ID: 354545
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of betamethasone and dexamethasone on the liver ultrastructure in rats.
    Garg BD; Khandekar JD; Dardachti DF; Kovacs K
    Indian J Med Res; 1971 Apr; 59(4):604-8. PubMed ID: 5567095
    [No Abstract]   [Full Text] [Related]  

  • 80. Warning: exposure of infants to potent topical steroids.
    Weston WL; Arthur J; Blakeman GH; Andresen M
    N Engl J Med; 1977 Jul; 297(4):222. PubMed ID: 876284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.